<- Go Home
Titan Pharmaceuticals, Inc.
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases in the United States and internationally.
Market Cap
$3.3M
Volume
6.7K
Cash and Equivalents
$4.1M
EBITDA
-$7.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$907.0K
Profit Margin
-30233.33%
52 Week High
$14.80
52 Week Low
$3.51
Dividend
N/A
Price / Book Value
0.83
Price / Earnings
-0.55
Price / Tangible Book Value
0.83
Enterprise Value
-$763.2K
Enterprise Value / EBITDA
0.11
Operating Income
-$7.1M
Return on Equity
-368.99%
Return on Assets
-172.63
Cash and Short Term Investments
$4.1M
Debt
N/A
Equity
$4.0M
Revenue
$3.0K
Unlevered FCF
-$5.2M
Sector
Pharmaceuticals
Category
N/A